On April 3, 2017, Mr. Peter O'Brien resigned his positions as President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer and was appointed Senior Vice President - European Operations. On April 3, 2017 the Reactive Medical Inc.'s board of directors increased the size of the Board to two members and appointed Gregory Gorgas as a member of the Board and as Company's the President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer. Prior to joining the Company, Mr. Gorgas was Senior Vice President, Commercial and Corporate Officer at Mast Therapeutics from July 2011 to January 2017 with commercial leadership accountability and business development responsibilities for the hematology, oncology and cardiovascular development programs. Mr. Gorgas currently serves as director at Theragence and on the advisory board at Klotho Therapeutics.